查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908494

導管導引線市場規模、佔有率和趨勢分析報告：按產品、地區和細分市場預測（2026-2033 年）

Guidewires Market Size, Share & Trends Analysis Report By Product (Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, Neurovascular Guidewires), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

導管導引線市場概覽

預計到 2025 年，全球導管導引線市場規模將達到 28.8 億美元，到 2033 年將達到 44.3 億美元。

預計從 2026 年到 2033 年，導絲市場將以 5.53% 的複合年成長率成長。導管導引線市場的成長受以下因素驅動：微創和導管介入手術數量的增加、心血管和周邊血管疾病盛行率的上升、導管導引線設計和材料的不斷進步以提高柔軟性和扭矩控制，以及全球醫院和門診手術中心介入手術的日益普及。

全球心血管疾病負擔日益加重，包括冠狀動脈疾病、周邊動脈疾病和結構性心臟疾病，這是導管導引線市場成長要素之一。隨著人口老化、久坐不動的生活方式、肥胖、糖尿病和高血壓等因素導致心血管疾病（CVD）發病率上升，醫院進行的診斷和介入手術數量不斷增加，例如血管成形術、支架置入術術、導管介入成像和微創血管修復術。導管導引線在這些手術中至關重要，它能夠引導導絲穿過複雜的血管、跨越阻塞部位並精準放置器械。此外，微創介入治療因其能夠縮短住院時間、減少併發症並改善患者預後而日益受到青睞，這也進一步推動了對高度專業導管導引線的需求。

此外，心絞痛是全球範圍內導致發病率和死亡率的主要原因之一，影響大量患者。例如，根據美國國家醫學圖書館的數據，2024年全球心絞痛盛行率約為2.0%至7.0%。此外，2023年中國報告的心絞痛病例超過280.6萬例。有證據表明，心絞痛會使嚴重心血管事件的風險增加一倍。目前，冠狀動脈疾病（CAD）每年在歐洲造成410萬人死亡，其中82.0%的死亡病例發生在65歲及以上的老年族群。

技術進步是推動導管導引線應用的關鍵因素之一。先進的導管導引線可依特定需求進行客製化，並可進行遠端控制，進而提高手術成功率，加速微創手術的普及。這些導管導引線與影像設備和手術機器人的結合，為現代外科手術的應用開闢了無限可能。例如，2024年4月，Teleflex推出了Watson臨時起搏導導管導引線，專為球囊主動脈瓣環成形（BAV）和經導管主動脈瓣置換術（TAVR）而設計。此導管導引線可提供瓣膜輸送輔助、雙重功能以及心室雙極起搏，旨在減少與傳統技術相關的併發症，並提高手術效率。

此外，人口老化進一步推動了市場成長。例如，根據世界衛生組織估計，到2030年，全球六分之一的人口將達到或超過60歲。預計到2050年，這一人口數將翻倍。此外，老年族群的疾病發生率也顯著高於其他族群，其中包括心血管疾病、缺血性心臟疾病、血管性失智症和多發性硬化症。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章導管導引線市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 導管導引線市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章導管導引線市場：產品、估算與趨勢分析

  • 導管導引線市場：按產品分類的差異分析
  • 導管導引線市場：產品展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 冠狀動脈導線
  • 末梢血管導管導引線
  • 泌尿系統導管導引線
  • 神經血管導管導引線

第5章導管導引線市場：區域、估算與趨勢分析

  • 區域儀錶板
  • 按地區分類的導管導引線市場波動分析
  • 導管導引線市場：按診斷和地區分類的估算和趨勢分析
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭情勢

  • 市場參與企業分類
  • 企業市場占有率分析，2025 年
  • 主要企業簡介
    • Boston Scientific Corporation
    • Medtronic
    • Cook
    • B. Braun
    • Terumo Medical Corporation
    • Abbott
    • Stryker
    • Teleflex Incorporated
    • Codman Neuro（Integer Holdings Corporation）
    • Merit Medical Systems
    • BD
    • Olympus Corporation
    • Asahi Intecc Co., Ltd.
    • ConMed Corporation
    • Argon Medical Devices
    • SP Medical A/S
    • TE Con​​nectivity（前身為 Creganna Medical）
    • Galt Medical Corp
    • Balton
    • Manish Medi Innovation
    • ST. Stone Medical Devices Private Limited
    • Custom Wire Technologies, Inc.
    • ACE Medical Devices
    • BrosMed Medical Co., Ltd.
    • Cathwide Medical Co. Ltd.
    • Creo Medical
    • Foshan Dihua Technology Co., Ltd.
    • AngioDynamics
    • Cordis（Cardinal Health）
Product Code: 978-1-68038-243-3

Guidewires Market Summary

The global guidewires market size was valued at USD 2.88 billion in 2025 and is projected to reach USD 4.43 billion by 2033, growing at a CAGR of 5.53% from 2026 to 2033. The growth of the guidewires market is driven by the rising volume of minimally invasive and catheter-based procedures, increasing prevalence of cardiovascular and peripheral vascular diseases, continuous advancements in guidewire design and materials to improve flexibility and torque control, and expanding adoption of interventional procedures across hospitals and ambulatory surgical centers worldwide.

The rising global burden of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and structural heart disorders, is one of the significant growth drivers for the guidewires market. As the incidence of CVD increases due to ageing populations, sedentary lifestyles, obesity, diabetes, and hypertension, hospitals are witnessing a higher volume of diagnostic and interventional procedures such as angioplasty, stent placement, catheter-based imaging, and minimally invasive vascular repairs. These procedures rely heavily on guidewires for navigating complex vasculature, crossing occlusions, and enabling precise device placement. Moreover, the growing preference for minimally invasive interventions, favored for shorter hospital stays, reduced complications, and better patient outcomes, further accelerates the demand for highly specialized guidewires.

Moreover, angina pectoris, a leading cause of morbidity and mortality globally, affects a significant number of individuals. For instance, according to the National Library of Medicine, the prevalence of angina pectoris worldwide ranged from approximately 2.0% to 7.0% in 2024. In addition, in 2023, there were over 2,806,000 reported cases of angina pectoris in China. There is evidence that angina doubles the risk of serious cardiovascular events. Currently, coronary artery disease (CAD) accounts for 4.1 million deaths in Europe annually, with individuals over 65 accounting for 82.0% of these deaths.

Technological advancements are one of the key factors boosting the application of the guidewire. The advanced guidewires can be customized for specific requirements and can be operated remotely. This leads to an increased success rate of the procedures and thus the adoption rate for minimally invasive surgeries. The integration of these guidewires with imaging modalities and surgical robots has endless applications in modern surgical practices. For instance, in April 2024, Teleflex Incorporated introduced the Wattson Temporary Pacing Guidewire, designed specifically for use during Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Replacement (TAVR). This guidewire offers supporting valve delivery, dual functionality, and ventricular bipolar pacing. It aims to improve procedural efficiencies and reduce complications associated with traditional methods.

Furthermore, rising geriatric population further fuels market growth. For instance, the WHO estimates that by 2030, 1 in 6 people worldwide will be 60 years of age or older. The same demographic will double by 2050. Moreover, diseases are far more common among older adults. These include cardiovascular disease, ischemic heart disease, vascular dementia, and multiple sclerosis, among others.

Global Guidewires Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the guidewires market report on the basis of product, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Guidewires Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising burden of cardiovascular & peripheral diseases
      • 3.2.1.2. Growing adoption of minimally invasive procedures
      • 3.2.1.3. Technological advancements in guidewire design
      • 3.2.1.4. Expansion of Cath labs and interventional centers
      • 3.2.1.5. Increasing stroke intervention adoption
      • 3.2.1.6. Strong industry presence & distribution networks
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Alternative treatment options
      • 3.2.2.2. Stringent regulatory requirements
      • 3.2.2.3. Potential risks and complications
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. High growth in emerging markets
      • 3.2.3.2. Adoption of robot-assisted & imaging-guided interventions
      • 3.2.3.3. Increased use of premium CTO & specialty wires
      • 3.2.3.4. Product differentiation through materials & coatings
      • 3.2.3.5. Local manufacturing & OEM opportunities
      • 3.2.3.6. Rising Focus on Neurovascular Interventions
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Supply chain constraints (nitinol & specialty coatings)
      • 3.2.4.2. Growing competition & market saturation
  • 3.3. Guidewires Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Guidewires Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Guidewires Market: Product Movement Analysis
  • 4.3. Guidewires Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Coronary Guidewires
    • 4.5.1. Coronary Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Peripheral Guidewires
    • 4.6.1. Peripheral Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Urology Guidewires
    • 4.7.1. Urology Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Neurovascular Guidewires
    • 4.8.1. Neurovascular Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Guidewires Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Guidewires Market movement analysis
  • 5.3. Guidewires Market: Regional Estimates & Trend Analysis by Diagnosis
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. North America
    • 5.5.1. North America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. U.S. Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Canada Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement scenario
      • 5.5.4.5. Mexico Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. UK Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Germany Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. France Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Italy Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Competitive Scenario
      • 5.6.6.3. Regulatory Framework
      • 5.6.6.4. Reimbursement scenario
      • 5.6.6.5. Spain Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.7. Denmark
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Competitive Scenario
      • 5.6.7.3. Regulatory Framework
      • 5.6.7.4. Reimbursement scenario
      • 5.6.7.5. Denmark Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Competitive Scenario
      • 5.6.8.3. Regulatory Framework
      • 5.6.8.4. Reimbursement scenario
      • 5.6.8.5. Sweden Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.9. Norway
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Competitive Scenario
      • 5.6.9.3. Regulatory Framework
      • 5.6.9.4. Reimbursement scenario
      • 5.6.9.5. Norway Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. Japan Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. China Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. India Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. South Korea Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.6. Australia
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Reimbursement scenario
      • 5.7.6.5. Australia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory Framework
      • 5.7.7.4. Reimbursement scenario
      • 5.7.7.5. Thailand Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory Framework
      • 5.8.2.4. Reimbursement scenario
      • 5.8.2.5. Brazil Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory Framework
      • 5.8.3.4. Reimbursement scenario
      • 5.8.3.5. Argentina Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Middle East & Africa
    • 5.9.1. Middle East & Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory Framework
      • 5.9.2.4. Reimbursement scenario
      • 5.9.2.5. South Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory Framework
      • 5.9.3.4. Reimbursement scenario
      • 5.9.3.5. Saudi Arabia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Competitive Scenario
      • 5.9.4.3. Regulatory Framework
      • 5.9.4.4. Reimbursement scenario
      • 5.9.4.5. UAE Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Competitive Scenario
      • 5.9.5.3. Regulatory Framework
      • 5.9.5.4. Reimbursement scenario
      • 5.9.5.5. Kuwait Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Company Share Analysis, 2025
  • 6.3. Key Company Profiles
    • 6.3.1. Boston Scientific Corporation
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Product benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Medtronic
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Product benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Cook
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Product benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. B. Braun
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Terumo Medical Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Abbott
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Stryker
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Teleflex Incorporated
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Codman Neuro (Integer Holdings Corporation)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Merit Medical Systems
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. BD
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Olympus Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Asahi Intecc Co., Ltd.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. ConMed Corporation
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Argon Medical Devices
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. SP Medical A/S
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives
    • 6.3.17. TE Connectivity (formerly Creganna Medical)
      • 6.3.17.1. Company overview
      • 6.3.17.2. Financial performance
      • 6.3.17.3. Product benchmarking
      • 6.3.17.4. Strategic initiatives
    • 6.3.18. Galt Medical Corp
      • 6.3.18.1. Company overview
      • 6.3.18.2. Financial performance
      • 6.3.18.3. Product benchmarking
      • 6.3.18.4. Strategic initiatives
    • 6.3.19. Balton
      • 6.3.19.1. Company overview
      • 6.3.19.2. Financial performance
      • 6.3.19.3. Product benchmarking
      • 6.3.19.4. Strategic initiatives
    • 6.3.20. Manish Medi Innovation
      • 6.3.20.1. Company overview
      • 6.3.20.2. Financial performance
      • 6.3.20.3. Product benchmarking
      • 6.3.20.4. Strategic initiatives
    • 6.3.21. ST. Stone Medical Devices Private Limited
      • 6.3.21.1. Company overview
      • 6.3.21.2. Financial performance
      • 6.3.21.3. Product benchmarking
      • 6.3.21.4. Strategic initiatives
    • 6.3.22. Custom Wire Technologies, Inc.
      • 6.3.22.1. Company overview
      • 6.3.22.2. Financial performance
      • 6.3.22.3. Product benchmarking
      • 6.3.22.4. Strategic initiatives
    • 6.3.23. ACE Medical Devices
      • 6.3.23.1. Company overview
      • 6.3.23.2. Financial performance
      • 6.3.23.3. Product benchmarking
      • 6.3.23.4. Strategic initiatives
    • 6.3.24. BrosMed Medical Co., Ltd.
      • 6.3.24.1. Company overview
      • 6.3.24.2. Financial performance
      • 6.3.24.3. Product benchmarking
      • 6.3.24.4. Strategic initiatives
    • 6.3.25. Cathwide Medical Co. Ltd.
      • 6.3.25.1. Company overview
      • 6.3.25.2. Financial performance
      • 6.3.25.3. Product benchmarking
      • 6.3.25.4. Strategic initiatives
    • 6.3.26. Creo Medical
      • 6.3.26.1. Company overview
      • 6.3.26.2. Financial performance
      • 6.3.26.3. Product benchmarking
      • 6.3.26.4. Strategic initiatives
    • 6.3.27. Foshan Dihua Technology Co., Ltd.
      • 6.3.27.1. Company overview
      • 6.3.27.2. Financial performance
      • 6.3.27.3. Product benchmarking
      • 6.3.27.4. Strategic initiatives
    • 6.3.28. AngioDynamics
      • 6.3.28.1. Company overview
      • 6.3.28.2. Financial performance
      • 6.3.28.3. Product benchmarking
      • 6.3.28.4. Strategic initiatives
    • 6.3.29. Cordis (Cardinal Health)
      • 6.3.29.1. Company overview
      • 6.3.29.2. Financial performance
      • 6.3.29.3. Product benchmarking
      • 6.3.29.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 4. North America Guidewires market, by region, 2021 - 2033 (USD Million)
  • Table 5. North America Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 6. U.S. Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 7. Canada Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 8. Mexico Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 9. Europe Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 10. Europe Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 11. UK Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 12. Germany Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 13. France Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 14. Italy Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 15. Spain Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 16. Norway Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 17. Sweden Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 18. Denmark Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 19. Asia Pacific Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 20. Asia Pacific Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 21. Japan Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 22. China Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 23. India Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 24. Australia Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 25. South Korea Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 26. Thailand Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 27. Latin America Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 28. Latin America Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 29. Brazil Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 30. Argentina Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 31. Middle East & Africa Guidewires market, by country, 2021 - 2033 (USD Million)
  • Table 32. Middle East & Africa Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 33. South Africa Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 34. Saudi Arabia Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 35. UAE Guidewires market, by product, 2021 - 2033 (USD Million)
  • Table 36. Kuwait Guidewires market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Guidewires market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Guidewires market, product outlook key takeaways (USD Million)
  • Fig. 12 Guidewires market product movement analysis 2023 & 2030 (USD Million)
  • Fig. 13 Coronary guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Peripheral guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Urology guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Neurovascular guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Guidewires market: Regional key takeaways (USD Million)
  • Fig. 18 Guidewires market regional outlook, 2023 & 2030 (USD Million)
  • Fig. 19 North America Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 US Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Canada Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Mexico Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Europe Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 UK Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Germany Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 France Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Spain Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Italy Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Sweden Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Norway Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Denmark Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Asia Pacific Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 China Guidewires estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Japan Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 India Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 South Korea Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Australia Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Thailand Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Latin America Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Brazil Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Argentina Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Middle East and Africa Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 South Africa Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Saudi Arabia Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 UAE Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Kuwait Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 List of key emerging company's/product type disruptors/innovators